GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » NanoRepro AG (XTER:NN6) » Definitions » EV-to-EBIT

NanoRepro AG (XTER:NN6) EV-to-EBIT : 1.76 (As of May. 30, 2025)


View and export this data going back to 2008. Start your Free Trial

What is NanoRepro AG EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, NanoRepro AG's Enterprise Value is €-8.33 Mil. NanoRepro AG's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was €-4.73 Mil. Therefore, NanoRepro AG's EV-to-EBIT for today is 1.76.

The historical rank and industry rank for NanoRepro AG's EV-to-EBIT or its related term are showing as below:

XTER:NN6' s EV-to-EBIT Range Over the Past 10 Years
Min: -59.99   Med: -3.56   Max: 57.07
Current: 1.77

During the past 13 years, the highest EV-to-EBIT of NanoRepro AG was 57.07. The lowest was -59.99. And the median was -3.56.

XTER:NN6's EV-to-EBIT is ranked better than
92.45% of 106 companies
in the Medical Diagnostics & Research industry
Industry Median: 20.185 vs XTER:NN6: 1.77

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. NanoRepro AG's Enterprise Value for the quarter that ended in Jun. 2024 was €-5.05 Mil. NanoRepro AG's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was €-4.73 Mil. NanoRepro AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 93.57%.


NanoRepro AG EV-to-EBIT Historical Data

The historical data trend for NanoRepro AG's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NanoRepro AG EV-to-EBIT Chart

NanoRepro AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.60 12.60 1.77 0.64 -1.01

NanoRepro AG Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.64 - -1.01 -

Competitive Comparison of NanoRepro AG's EV-to-EBIT

For the Diagnostics & Research subindustry, NanoRepro AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NanoRepro AG's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, NanoRepro AG's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where NanoRepro AG's EV-to-EBIT falls into.


;
;

NanoRepro AG EV-to-EBIT Calculation

NanoRepro AG's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=-8.329/-4.725
=1.76

NanoRepro AG's current Enterprise Value is €-8.33 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. NanoRepro AG's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was €-4.73 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NanoRepro AG  (XTER:NN6) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

NanoRepro AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2024 ) =EBIT / Enterprise Value (Q: Jun. 2024 )
=-4.725/-5.049615
=93.57 %

NanoRepro AG's Enterprise Value for the quarter that ended in Jun. 2024 was €-5.05 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. NanoRepro AG's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was €-4.73 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NanoRepro AG EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of NanoRepro AG's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


NanoRepro AG Business Description

Traded in Other Exchanges
N/A
Address
Untergasse 8, Marburg, DEU, 35037
NanoRepro AG is engaged in the development, manufacturing, and distribution of CE-certified rapid diagnostic tests (self-tests) and food supplements for both, home and professional use.
Executives
Dr. Olaf Stiller Supervisory Board
Andre Schulte-südhoff Supervisory Board
Lisa Jüngst Board of Directors
Michael Tillmann Supervisory Board

NanoRepro AG Headlines

No Headlines